AI in Biotech: Powering the Next Generation of Synthetic Biology

When you think of collagen, you probably picture glowing skin. The truth? Traditional collagen production comes at a cost—it still relies on cows, pigs, or fish, sourced from slaughterhouses and industrial fisheries before being processed into powders and serums.

Cambrium is reinventing the industry with NovaColl™, the world’s first micro-molecular, skin-identical collagen developed through AI in biotech and precision fermentation. The result? A sustainable, scalable, and animal-free solution that redefines the future of cosmetics.

Explore our Science Decoding report

Why AI in Biotech Matters

Artificial intelligence is no longer just a tool for data—it’s becoming a core driver of biotech innovation. By combining AI algorithms with synthetic biology, Cambrium is able to design proteins with superior performance and tailor them for specific applications.

With AI, biotech companies can:

• Accelerate protein design and testing

• Optimize precision fermentation processes

• Scale production while reducing costs and environmental impact

This is biotech powered by intelligence, not extraction.

NovaColl™: Collagen Reinvented

• Animal-free and vegan: No livestock, no fisheries—just engineered molecules.

• 100% skin-identical: Designed for deep penetration and higher efficacy in skincare.

• Sustainable and scalable: Uses less land, water, and energy compared to animal-based collagen.

NovaColl™ proves how AI in biotech can deliver high-performance, ethical, and sustainable materials for the personal care and cosmetics industries.

The future of cosmetics and personal care isn’t extracted. It’s engineered. As the most powerful manufacturing technology, synthetic biology is transforming sustainable material innovation.